Next, having identified chimeras of hASNase1 and gpASNase1 whose KM Asn is in the micromolar range, we evaluated the anti-ALL potency of three clones by comparing them to gpASNase1. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.